Literature DB >> 11502221

Identification of the beta-dystroglycan binding epitope within the C-terminal region of alpha-dystroglycan.

F Sciandra1, M Schneider, B Giardina, S Baumgartner, T C Petrucci, A Brancaccio.   

Abstract

Dystroglycan is a receptor for extracellular matrix proteins that plays a crucial role during embryogenesis in addition to adult tissue stabilization. A precursor product of a single gene is post-translationally cleaved to form two different subunits, alpha and beta. The extracellular alpha-dystroglycan is a membrane-associated, highly glycosylated protein that binds to various extracellular matrix molecules, whereas the transmembrane beta-dystroglycan binds, via its cytosolic domain, to dystrophin and many other proteins. alpha- and beta-Dystroglycan interact tightly but noncovalently. We have previously shown that the N-terminal region of beta-dystroglycan, beta-DG(654-750), binds to the C-terminal region of murine alpha-dystroglycan independently from glycosylation. Preparing a series of deleted recombinant fragments and using solid-phase binding assays, the C-terminal sequence of alpha-dystroglycan containing the binding epitope for beta-dystroglycan has been defined more precisely. We found that a region of 36 amino acids, from position 550-585, is required for binding the extracellular region, amino acids 654-750 of beta-dystroglycan. Recently, a dystroglycan-like gene was identified in Drosophila that showed a moderate degree of conservation with vertebrate dystroglycan (31% identity, 48% similarity). Surprisingly, the Drosophila sequence contains a region showing a higher degree of identity and conservation (45% and 66%) that coincides with the 550-585 sequence of vertebrate alpha-dystroglycan. We have expressed this Drosophila dystroglycan fragment and measured its binding to the extracellular region of vertebrate (murine) beta-dystroglycan (Kd = 6 +/- 1 microM). These data confirm the proper identification of the beta-dystroglycan binding epitope and stress the importance of this region during evolution. This finding might help the rational design of dystroglycan-specific binding drugs, that could have important biomedical applications.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11502221     DOI: 10.1046/j.1432-1327.2001.02386.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  8 in total

1.  Perlecan and Dystroglycan act at the basal side of the Drosophila follicular epithelium to maintain epithelial organization.

Authors:  Martina Schneider; Ashraf A Khalil; John Poulton; Casimiro Castillejo-Lopez; Diane Egger-Adam; Andreas Wodarz; Wu-Min Deng; Stefan Baumgartner
Journal:  Development       Date:  2006-08-30       Impact factor: 6.868

2.  Dystroglycan expression is frequently reduced in human breast and colon cancers and is associated with tumor progression.

Authors:  Alessandro Sgambato; Mario Migaldi; Micaela Montanari; Andrea Camerini; Andrea Brancaccio; Giulio Rossi; Rodolfo Cangiano; Carmen Losasso; Giovanni Capelli; Gian Paolo Trentini; Achille Cittadini
Journal:  Am J Pathol       Date:  2003-03       Impact factor: 4.307

3.  Formation of multiple complexes between beta-dystroglycan and dystrophin family products.

Authors:  M Royuela; D Chazalette; G Hugon; R Paniagua; V Guerlavais; J A Fehrentz; J Martinez; J P Labbe; F Rivier; D Mornet
Journal:  J Muscle Res Cell Motil       Date:  2003       Impact factor: 2.698

4.  The evolution of the dystroglycan complex, a major mediator of muscle integrity.

Authors:  Josephine C Adams; Andrea Brancaccio
Journal:  Biol Open       Date:  2015-08-28       Impact factor: 2.422

5.  Proteasome inhibitor (MG-132) treatment of mdx mice rescues the expression and membrane localization of dystrophin and dystrophin-associated proteins.

Authors:  Gloria Bonuccelli; Federica Sotgia; William Schubert; David S Park; Philippe G Frank; Scott E Woodman; Luigi Insabato; Michael Cammer; Carlo Minetti; Michael P Lisanti
Journal:  Am J Pathol       Date:  2003-10       Impact factor: 4.307

6.  Duplication of the dystroglycan gene in most branches of teleost fish.

Authors:  Ernesto Pavoni; Davide Cacchiarelli; Roberta Tittarelli; Massimiliano Orsini; Antonio Galtieri; Bruno Giardina; Andrea Brancaccio
Journal:  BMC Mol Biol       Date:  2007-05-17       Impact factor: 2.946

Review 7.  A molecular overview of the primary dystroglycanopathies.

Authors:  Andrea Brancaccio
Journal:  J Cell Mol Med       Date:  2019-03-05       Impact factor: 5.310

8.  The effect of an ionic detergent on the natively unfolded beta-dystroglycan ectodomain and on its interaction with alpha-dystroglycan.

Authors:  Manuela Bozzi; Enrico Di Stasio; Daniel O Cicero; Bruno Giardina; Maurizio Paci; Andrea Brancaccio
Journal:  Protein Sci       Date:  2004-08-04       Impact factor: 6.725

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.